• 12-O-tetradecanoyl phorbol-13-acetate: ERK/MAPK Pathway Acti

  2026-05-27

  12-O-tetradecanoyl phorbol-13-acetate (TPA) is a potent and reliable activator of the ERK/MAPK signaling pathway, primarily through protein kinase C modulation. TPA is widely used in signal transduction research and skin cancer models due to its rapid, tunable effects and robust benchmark data. Its storage, solubility, and experimental handling are well-defined, ensuring reproducible results in preclinical and mechanistic studies.

• Tubastatin A Attenuates Post-Resuscitation Cardiac Injury vi

  2026-05-27

  A recent porcine study demonstrates that Tubastatin A, a highly selective HDAC6 inhibitor, mitigates myocardial injury after cardiac arrest and resuscitation by suppressing both GSDME-mediated pyroptosis and MLKL-mediated necroptosis. These findings provide mechanistic insight into HDAC6 inhibition as a strategy for cardioprotection following ischemia-reperfusion injury.

• Disodium Bicinchoninate in Cardiac Fibrosis Assays: Mechanis

  2026-05-26

  Explore how disodium bicinchoninate, a water-soluble small molecule, advances cardiac fibrosis and apoptosis research. This article provides mechanistic depth, unique protocol guidance, and context from recent landmark studies.

• Decoding Dual-Fluorescence: EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-05-26

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) redefines Cy5-labeled mRNA delivery with dual-fluorescence quantification and immune evasion. This in-depth analysis uniquely bridges mechanistic insight with assay optimization strategies.

• Artesunate in Cancer Research: Integrative Mechanisms and In

  2026-05-25

  Explore Artesunate, a potent artemisinin derivative, as a multifaceted tool for in vitro cancer research. This article uniquely connects mechanistic insight to assay strategy, helping researchers optimize experimental design and interpretation.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Gut Flo

  2026-05-25

  The reference study demonstrates that Shufeng Xingbi Therapy significantly alleviates allergic rhinitis (AR) symptoms in rats by restoring Th1/Th2 immune balance and reshaping intestinal microbiota. These findings provide mechanistic insight into the therapy’s dual immunomodulatory and microbiota-targeting effects, supporting its potential as an experimental model for immune-allergy research.

• G418 Sulfate (Geneticin): Selective Power & Antiviral Benchm

  2026-05-24

  G418 Sulfate (Geneticin) is a potent genetic engineering selection antibiotic with well-characterized ribosomal inhibition and emerging antiviral activity. Its dual functionality—precise selection for neomycin-resistant cells and inhibition of Dengue virus—makes it indispensable for cell line development and virology workflows. This article details verifiable mechanisms, application boundaries, and protocol parameters.

• Pemetrexed Disodium: Advanced Insights for DNA Repair Defect

  2026-05-23

  Explore how pemetrexed disodium, a multi-targeted antifolate, enables next-generation research into DNA repair defects and chemoresistance in cancer models. This in-depth analysis reveals unique protocol strategies and translational outlooks for using pemetrexed in complex tumor biology.

• Trelagliptin Promotes RUNX2-Driven Osteoblastic Differentiat

  2026-05-22

  This study reveals that trelagliptin, a DPP-4 inhibitor, enhances osteoblastic differentiation by upregulating RUNX2 via an AMPK-dependent pathway in MC3T3-E1 cells. The findings suggest a novel therapeutic implication for osteoporosis, expanding the potential utility of trelagliptin beyond glycemic control.

• KR-12 Human Antimicrobial Peptide: Applied Research & Protoc

  2026-05-22

  KR-12 (human) TFA is the minimal LL-37-derived antimicrobial peptide, uniquely balancing potent anti-biofilm, LPS-neutralizing, and low-cytotoxicity properties for translational infection models. This article details actionable experimental workflows, troubleshooting strategies, and advanced use-cases, empowering researchers to harness KR-12's multi-functional bioactivity with confidence.

• mTORC1-IRE1α Pathway Drives Palmitate-Induced Hepatocyte Inj

  2026-05-21

  This study uncovers a mechanistic link between mTORC1 activation and IRE1α-mediated endoplasmic reticulum stress in hepatocytes exposed to saturated fatty acids. The findings clarify how palmitate triggers triglyceride overproduction and cell death, highlighting new targets for metabolic disorder therapies.

• Amiloride (MK-870): Transforming Sodium Channel Research Wor

  2026-05-21

  Amiloride (MK-870) from APExBIO redefines sodium channel and endocytosis studies with unmatched selectivity and reproducibility. This guide brings together optimized protocols, troubleshooting strategies, and insights from the latest clinical research to empower ion transport and disease modeling workflows.

• Entecavir (BMS200475): Advances in Chronic Hepatitis B Thera

  2026-05-20

  The reference study by Zoulim (2006) establishes Entecavir (BMS200475) as a highly potent and selective inhibitor of hepatitis B virus (HBV) replication, demonstrating superior efficacy and resistance profile compared to previous nucleoside analogs such as lamivudine. These findings have significant implications for improving long-term outcomes in both treatment-naïve and lamivudine-resistant chronic hepatitis B patients.

• SR 11302: AP-1 Transcription Factor Inhibitor for Precision

  2026-05-20

  SR 11302 empowers researchers to dissect AP-1-driven oncogenic pathways with remarkable selectivity, enabling high-fidelity cancer cell proliferation and immunomodulation assays. Its unique mechanism allows targeted inhibition of tumor promotion with minimized off-target effects, setting a new benchmark for chemoprevention and mechanistic oncology studies.

• Wortmannin in Translational Research: Mechanisms, Workflows,

  2026-05-19

  This thought-leadership article explores how Wortmannin, a potent and selective PI3K inhibitor, empowers translational researchers to dissect complex signaling pathways implicated in cancer, autophagy, and emerging viral immune evasion mechanisms. We integrate mechanistic insights, experimental best practices, and cross-domain strategy, referencing recent findings on IRF7 degradation during viral replication. This resource expands beyond standard product pages by connecting biological rationale, protocol optimization, and visionary outlook for both cancer and infectious disease research.

16946 records 1/1130 page Next 12345 下5页 Last page